FUCHS HENRY J

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
72
Insider Sells Sum
$73.39M

Insider Activity of FUCHS HENRY J

According to the SEC Form 4 filings, FUCHS HENRY J, being in a position of

  1. President, Worldwide R&D at BioMarin Pharmaceutical Inc.,
    оver the last 12 months, has bought 0 shares, and sold 35341 share for $3.01M,
    over all time since 2010-04-01, has bought 0 shares, and sold 932331 share for $73.39M.

The largest sale of all time was on 2020-07-20 and amounted to 126389 shares of BioMarin Pharmaceutical Inc. for $16.43M.

Biography of FUCHS HENRY J

No biography is available at this moment.

2024-03-05SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
35,341
0.0186%
$85.18$3.01M-4.35%
2023-08-10SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
12,000
0.0064%
$90.43$1.09M-3.82%
2020-07-20SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
126,389
0.0692%
$130.00$16.43M-39.88%
2020-07-13SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
23,011
0.0133%
$130.00$2.99M-36.66%
2020-04-24SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
20,000
0.0109%
$95.88$1.92M-15.98%
2020-04-20SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
17,213
0.0092%
$90.00$1.55M-11.52%
2019-03-25SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
11,864
0.0066%
$87.86$1.04M-7%
2019-03-18SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
19,194
0.0109%
$94.09$1.81M-11.4%
2019-03-04SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
4,392
0.0025%
$95.00$417,240-10.94%
2018-08-27SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
25,000
0.0141%
$100.00$2.5M-8.72%
2018-08-24SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
25,000
0.0142%
$99.50$2.49M-7.52%
2018-06-14SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
24,556
0.013%
$84.43$2.07M+4.69%
2018-04-02SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
10,000
0.0045%
$62.15$621,540+21.87%
2018-01-02SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
30,000
0.0167%
$89.23$2.68M+1.33%
2017-09-15SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
30,000
0.0169%
$90.50$2.71M-2.32%
2017-06-19SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
1,206
0.0007%
$90.00$108,540-3.79%
2017-06-16SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
19,397
0.0093%
$73.63$1.43M-0.84%
2017-02-24SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
30,000
0.0114%
$57.24$1.72M+2.58%
2016-11-25SaleBioMarin Pharmaceutical Inc.
BMRN
President, Worldwide R&D
30,000
0.0112%
$56.94$1.71M+0.09%
2016-08-26SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Medical Officer
30,000
0.0113%
$60.78$1.82M-7.26%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.